Experimental mRNA vaccine shows promise in preventing melanoma recurrence

An experimental mRNA drug has been found to prevent melanoma from returning in patients, marking a potential breakthrough in skin cancer treatment. More than 8,500 Americans are expected to die of melanoma this year. Researchers describe the findings as a significant step forward in cancer immunology.